Bulgaria's Sopharma Trading pre-tax profit grows 13% y/y in Jan-Feb

The company's sales revenue grew by an annual 12% to some 234 million levs in January-February, Sopharma Trading said in a stock exchange filing on Thursday.

In February alone, Sopharma Trading's pre-tax profit came in at 4.36 million levs, up by 55% in annual terms, while its sales increased by 17% year-on-year to 114.1 million levs.

On a consolidated basis, the company's revenue climbed by a yearly 12% to 309.4 million levs in January-February, whereas its pre-tax profit leapt by 21% to 10.8 million levs.

The company is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:SFA]. Shares in Sopharma Trading last traded on Thursday when they closed at 5.75 levs on the Bulgarian Stock Exchange, bourse data show.

(1 euro = 1.95583 levs)